Cingulate Correlations

CING Stock

USD 5.61 0.17 3.12%

The current 90-days correlation between Cingulate and Lexaria Bioscience Corp is 0.27 (i.e., Modest diversification). The correlation of Cingulate is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cingulate Correlation With Market

Very weak diversification

The correlation between Cingulate and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Cingulate Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

Moving together with Cingulate Stock

0.66	VERA	Vera Therapeutics	Pair Corr
0.77	DRUG	Bright Minds Biosciences	Pair Corr
0.91	DRTS	Alpha Tau Medical	Pair Corr
0.83	0P6S	Bayer AG NA	Pair Corr
0.78	DVAX	Dynavax Technologies	Pair Corr
0.78	VNDA	Vanda Pharmaceuticals	Pair Corr

Moving against Cingulate Stock

0.71	CMB	Cambium Bio	Pair Corr
0.51	VANI	Vivani Medical	Pair Corr
0.51	DRMA	Dermata Therapeutics	Pair Corr
0.79	DWTX	Dogwood Therapeutics	Pair Corr
0.67	PYC	Physiomics Plc	Pair Corr
0.57	DTIL	Precision BioSciences	Pair Corr
0.52	VKTX	Viking Therapeutics	Pair Corr
0.36	VIVS	VivoSim Labs Symbol Change	Pair Corr
0.33	DYAI	Dyadic International	Pair Corr
0.75	BSFA	BSF Enterprise Plc	Pair Corr
0.73	VTGN	VistaGen Therapeutics	Pair Corr
0.61	CDTTW	Conduit Pharmaceuticals	Pair Corr
0.57	MRVL	Marvel Biosciences Corp	Pair Corr
0.56	VSTM	Verastem	Pair Corr
0.47	VRAX	Virax Biolabs Group	Pair Corr
0.43	EDIT	Editas Medicine	Pair Corr
0.39	EDSA	Edesa Biotech	Pair Corr

Related Correlations Analysis

	ALLR	LEXX	LIXT	KAPA	SYBX	CASI	CLSD	ENTO	NCNA	BCTX
ALLR		0.24	0.38	0.9	0.68	0.85	0.4	0.31	0.72	0.61	ALLR
LEXX	0.24		0.5	0.09	0.41	0.32	0.24	0.67	0.24	0.46	LEXX
LIXT	0.38	0.5		0.32	0.65	0.52	0.78	0.69	0.45	0.61	LIXT
KAPA	0.9	0.09	0.32		0.55	0.81	0.4	0.23	0.74	0.64	KAPA
SYBX	0.68	0.41	0.65	0.55		0.86	0.59	0.66	0.38	0.48	SYBX
CASI	0.85	0.32	0.52	0.81	0.86		0.53	0.49	0.61	0.58	CASI
CLSD	0.4	0.24	0.78	0.4	0.59	0.53		0.46	0.59	0.65	CLSD
ENTO	0.31	0.67	0.69	0.23	0.66	0.49	0.46		0.12	0.54	ENTO
NCNA	0.72	0.24	0.45	0.74	0.38	0.61	0.59	0.12		0.68	NCNA
BCTX	0.61	0.46	0.61	0.64	0.48	0.58	0.65	0.54	0.68		BCTX
	ALLR	LEXX	LIXT	KAPA	SYBX	CASI	CLSD	ENTO	NCNA	BCTX

Please upgrade your account to get full access to Macroaxis premium features

Risk-Adjusted Indicators

There is a big difference between Cingulate Stock performing well and Cingulate Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cingulate's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ALLR	3.63	(0.47)	0.00	(0.15)	0.00	0.00	7.07	(7.48)	19.82
LEXX	4.94	(0.05)	0.00	0.06	8.58	(4.74)	9.23	(9.68)	46.84
LIXT	3.13	(0.36)	0.00	2.33	0.00	0.00	7.19	(6.85)	17.52
KAPA	4.37	(0.70)	0.00	(0.16)	0.00	0.00	9.41	(9.28)	26.15
SYBX	2.76	(0.64)	0.00	(0.79)	0.00	0.00	4.72	(8.45)	19.19
CASI	3.82	(1.04)	0.00	(0.34)	0.00	0.00	5.88	(7.69)	28.12
CLSD	6.75	(3.09)	0.00	(2.94)	0.00	0.00	7.96	(17.54)	83.67
ENTO	6.86	0.79	0.08	3.70	7.81	(7.43)	16.50	(17.06)	56.75
NCNA	3.57	(0.89)	0.00	(0.53)	0.00	0.00	6.97	(7.92)	16.72
BCTX	7.04	(0.94)	0.00	(0.31)	0.00	0.00	13.96	(9.09)	98.43

Cingulate Corporate Management

Craig Esq	Gen VP	Profile
Thomas Dalton	Head Relations	Profile
Bryan Downey	Chief Officer	Profile
Downey Wade	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC